Five patients have died suddenly after surgery to implant liquid-filled intragastic balloons to treat obesity, US FDA announced in an Aug. 10 safety alert.
Four of the deaths involved the Orbera Intragastric Balloon System, manufactured by Apollo Endosurgery Inc., while one involved the ReShape Medical Inc.’s Integrated Dual Balloon System. Three of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?